Cargando…
Blockade of growth hormone secretagogue receptor 1A signaling by JMV 2959 attenuates the NMDAR antagonist, phencyclidine-induced impairments in prepulse inhibition
RATIONALE: Schizophrenic-spectrum patients commonly display deficits in preattentive information processing as evidenced, for example, by disrupted prepulse inhibition (PPI), a measure of sensorimotor gating. Similar disruptions in PPI can be induced in rodents and primates by the psychotomimetic dr...
Autores principales: | Engel, Jörgen A., Jerlhag, Elisabet, Svensson, Lennart, Smith, Roy G., Egecioglu, Emil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613889/ https://www.ncbi.nlm.nih.gov/pubmed/26319159 http://dx.doi.org/10.1007/s00213-015-4054-3 |
Ejemplares similares
-
Growth Hormone Secretagogue Receptor 1A Antagonist JMV2959 Effectively Prevents Morphine Memory Reconsolidation and Relapse
por: Zhao, Jing, et al.
Publicado: (2021) -
Ghrelin receptor antagonist JMV2959 blunts cocaine and oxycodone drug-seeking, but not self-administration, in male rats
por: Merritt, Christina R., et al.
Publicado: (2023) -
The Glucagon-Like Peptide 1 Analogue Exendin-4 Attenuates the Nicotine-Induced Locomotor Stimulation, Accumbal Dopamine Release, Conditioned Place Preference as well as the Expression of Locomotor Sensitization in Mice
por: Egecioglu, Emil, et al.
Publicado: (2013) -
The Glucagon-Like Peptide 1 Analogue, Exendin-4, Attenuates the Rewarding Properties of Psychostimulant Drugs in Mice
por: Egecioglu, Emil, et al.
Publicado: (2013) -
Glutamatergic regulation of ghrelin-induced activation of the mesolimbic dopamine system
por: Jerlhag, Elisabet, et al.
Publicado: (2011)